Breast Cancer Detection using Ultrasound Tomography: From Research to Clinical Practice
Event details
| Date | 26.06.2015 |
| Hour | 10:15 |
| Speaker | Olivier Roy, Delphinus Medical Technologies, USA, and Karmanos Cancer Institute, USA |
| Location | |
| Category | Conferences - Seminars |
Breast cancer is one of the leading causes of mortality among women. In the United States, recent statistics have shown that approximatively 12.3% of women will be diagnosed with breast cancer at some point during their lifetime.
The current gold standard for breast cancer screening is mammography. While mammography has been demonstrated to reduce mortality, it involves radiation, compression, and is known to perform poorly for women with dense breast tissue who are at a much higher risk for developing breast cancer.
To address the limitations of the current breast cancer screening technologies, we have developed SoftVue, a whole breast ultrasound imaging system based on the principles of ultrasound tomography.
In this presentation, I will describe our technology, and explain some of the technical, clinical, and regulatory challenges associated with bringing a research prototype to the market.
Bio: Olivier Roy received the M.Sc. degree in communication systems from the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland, in 2004, and the Ph.D. degree from the same institution in 2008.
From October 2004 to November 2008, he was a Research Assistant at the Audiovisual Communications Laboratory at EPFL. From June to August 2007, he joined Phonak, a hearing aid company based in Stäfa, Switzerland, to develop noise reduction schemes for binaural hearing aids. He was a visiting lecturer at EPFL from March to July 2009. From September 2009 to August 2010, he was a Post-doctoral Fellow at the Karmanos Cancer Institute in Detroit MI. He developed ultrasound tomography algorithms for breast imaging. In September 2010 he became a founding member of Delphinus Medical Technologies, a start-up company commercializing a fast, reliable, operator independent, and non-ionizing modality for breast cancer detection. He has held various positions at Delphinus, and is now its Director of Research and Development. Since September 2011, he has also held an Adjunct Assistant Professor position in the Department of Radiation Oncology at the Karmanos Cancer Institute.
His research interests are in sampling, distributed estimation and coding, microphone array processing, de-noising, inverse problems, and ultrasound tomography.
The current gold standard for breast cancer screening is mammography. While mammography has been demonstrated to reduce mortality, it involves radiation, compression, and is known to perform poorly for women with dense breast tissue who are at a much higher risk for developing breast cancer.
To address the limitations of the current breast cancer screening technologies, we have developed SoftVue, a whole breast ultrasound imaging system based on the principles of ultrasound tomography.
In this presentation, I will describe our technology, and explain some of the technical, clinical, and regulatory challenges associated with bringing a research prototype to the market.
Bio: Olivier Roy received the M.Sc. degree in communication systems from the Ecole Polytechnique Fédérale de Lausanne (EPFL), Switzerland, in 2004, and the Ph.D. degree from the same institution in 2008.
From October 2004 to November 2008, he was a Research Assistant at the Audiovisual Communications Laboratory at EPFL. From June to August 2007, he joined Phonak, a hearing aid company based in Stäfa, Switzerland, to develop noise reduction schemes for binaural hearing aids. He was a visiting lecturer at EPFL from March to July 2009. From September 2009 to August 2010, he was a Post-doctoral Fellow at the Karmanos Cancer Institute in Detroit MI. He developed ultrasound tomography algorithms for breast imaging. In September 2010 he became a founding member of Delphinus Medical Technologies, a start-up company commercializing a fast, reliable, operator independent, and non-ionizing modality for breast cancer detection. He has held various positions at Delphinus, and is now its Director of Research and Development. Since September 2011, he has also held an Adjunct Assistant Professor position in the Department of Radiation Oncology at the Karmanos Cancer Institute.
His research interests are in sampling, distributed estimation and coding, microphone array processing, de-noising, inverse problems, and ultrasound tomography.
Practical information
- General public
- Free
Organizer
- Vetterli Martin <[email protected]>
Contact
- Vetterli Martin <[email protected]>